CGC Stock Risk & Deep Value Analysis
Canopy Growth Corp
DVR Score
out of 10
What You Need to Know About CGC Stock
We analyzed Canopy Growth Corp using our deep value framework. Sign in to see our full verdict and DVR Score.
We ran CGC through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Our risk assessment: Aggressive. Here's what we found.
CGC Risk Analysis & Red Flags
What Could Go Wrong
U.S. federal cannabis legalization (e.g., SAFE Banking or DEA rescheduling efforts) could face continued legislative or political delays, preventing Canopy Growth from fully executing its Acreage Holdings acquisition and capitalizing on the significant U.S. market opportunity within the 3-5 year timeframe, thus limiting its 10x growth potential and prolonging its path to profitability. This uncertainty could hinder the company's ability to turn its improved financial health into sustained operational success.
Risk Matrix
Overall
Aggressive
Financial
Medium
Market
High
Competitive
High
Execution
Medium
Regulatory
High
Red Flags
- ⚠
Declining gross margin: 12% in Q4 FY2026, down from 16% in Q4 FY2025, indicates pricing pressure and impacts profitability trajectory.
- ⚠
History of multi-year financial restatements and material control weakness, disclosed in the annual report, impacts investor trust and confidence in financial reporting.
- ⚠
Primary growth thesis is heavily dependent on a single, uncertain external catalyst (U.S. federal cannabis legalization).
- ⚠
Adjusted EBITDA is still a loss of $6.3M in Q4 FY2026, implying continued cash burn although reduced.
Upcoming Risk Events
- 📅
U.S. Federal Legalization Delays (Ongoing): If U.S. federal cannabis legalization efforts stall beyond 2027, preventing the full integration of Acreage Holdings, it would significantly delay the primary 10x growth catalyst.
- 📅
Declining Gross Margin (Q1 FY2027 earnings): If Q1 FY2027 gross margin falls below 10%, it would signal severe pricing pressure and intensify concerns about the company's long-term profitability and competitive position.
When to Reconsider
- 🚪
Exit if quarterly cannabis net revenue growth falls below 5% YoY for two consecutive quarters.
- 🚪
Sell if the net cash position drops below $50M, indicating renewed cash burn and liquidity concerns.
- 🚪
Exit if U.S. federal legalization efforts show no significant legislative progress or major setbacks for another 12-18 months.
Unlock CGC Risk Analysis & Red Flags
Create a free account to see the full analysis
Investment Thesis
If U.S. federal cannabis legalization (e.g., SAFE Banking or DEA rescheduling) progresses significantly within the next 18-36 months, then Canopy Growth is strategically positioned through its Acreage Holdings acquisition to capture substantial market share in the massive U.S. market, potentially re-rating its valuation to several billion dollars in revenue, which is not currently priced into its sub-$1B market cap, especially with its recent financial stabilization and strong cannabis revenue growth in Q4 FY2026.
Is CGC Stock Undervalued?
Unlock the full AI analysis for CGC
Get the complete DVR score, risk analysis, and more
Unlock the full report
Create a free account to see the DVR score, risk flags, and AI analysis.
CGC Price Targets & Strategy
12-Month Target
$1.74
Bull Case
$3.69
Bear Case
$0.75
Valuation Basis
Based on analyst mean price target. Implies a forward P/S ratio of 3-4x on projected FY2027 revenue if growth continues, aligning with speculative growth stocks in nascent industries.
Entry Strategy
Dollar-cost average between $0.90-$1.00, targeting recent support levels. A sustained break above $1.20 could signal further upward momentum.
Exit Strategy
Take 50% profit at $1.70, remaining profit at $3.00+. Set stop-loss at $0.75 to protect capital on breakdown.
Portfolio Allocation
2-4% for aggressive risk tolerance.
Price Targets & Strategy
Sign up free to unlock price targets and entry/exit strategies
Is CGC Financially Healthy?
Valuation
P/E Ratio
-0.78
Profitability
Gross Margin
26.56%
Operating Margin
-30.71%
Net Margin
-117.31%
Return on Equity
-52.88%
Revenue Growth
0.59%
EPS
$-1.84
Balance Sheet
Current Ratio
3.12
Quick Ratio
2.04
Debt/Equity
0.67
Cash Flow
Free Cash Flow
-$69.10M
EBITDA
-$9.19M
Other
Beta (Volatility)
2.07
Does CGC Have a Competitive Moat?
Sign in to unlockMoat Rating
⚪ None
Moat Trend
Eroding
Moat Sources
2 Identified
The cannabis industry is highly competitive and susceptible to commoditization. While Canopy Growth has established brands, these are not sufficiently protected to create a durable, long-term moat against new entrants or pricing pressures. Regulatory barriers in emerging markets (like the U.S.) could temporarily create a moat, but this is contingent and not inherent to the business model.
Moat Erosion Risks
- •Increased commoditization and pricing pressure in the cannabis market, further eroding gross margins.
- •Entry of well-capitalized consumer packaged goods (CPG) companies into the cannabis space post-legalization, leveraging superior branding and distribution.
- •Lack of truly proprietary IP or unique cultivation methods that provide a significant cost advantage.
CGC Competitive Moat Analysis
Sign up to see competitive advantages
CGC Market Intelligence
Sentiment & Insider Activity
Social Sentiment
Neutral. Retail sentiment is often speculative on cannabis stocks, awaiting U.S. regulatory shifts, but recent financial stability provides some relief.
Institutional Sentiment
Neutral to Positive. Analyst consensus is 3.57 ('Hold to Buy') with a mean price target of $1.74, indicating cautious optimism tempered by market risks.
Insider Activity (Form 4)
No specific Form 4 filings or insider trade details for the last 90 days were provided in this research run.
Options Flow
Normal options activity. No specific unusual options flow data was provided in this research run.
Earnings Intelligence
Next Earnings
Estimated early August 2026 (for Q1 FY2027)
Surprise Probability
Medium
Historical Earnings Pattern
Historically, CGC's stock price has shown significant volatility around earnings, reacting strongly to revenue beats/misses, guidance, and, crucially, any updates regarding U.S. federal cannabis legislation.
Key Metrics to Watch
Competitive Position
Top Competitor
Tilray Brands (TLRY)
Market Share Trend
Stable to Gaining in Canada's medical and adult-use markets, as evidenced by strong cannabis net revenue growth in Q4 FY2026.
Valuation vs Peers
Currently trading at a discount on profitability metrics (e.g., P/E, EV/EBITDA) due to ongoing losses, but potentially comparable on Price/Sales to other Canadian LPs when factoring in its U.S. optionality.
Competitive Advantages
- •Established brand recognition and distribution networks in Canada's federally legal market.
- •Strategic positioning for U.S. market entry through the contingent acquisition of Acreage Holdings.
- •Improved financial liquidity and balance sheet strength relative to many peers facing capital constraints.
Market Intelligence
Sign up free to unlock sentiment, earnings intel, and peer analysis
What Could Drive CGC Stock Higher?
Near-Term (0-6 months)
- •Q1 FY2027 Earnings Report (Estimated late August 2026): Continued improvement in adjusted EBITDA and cannabis net revenue growth >15% YoY would confirm operational traction and validate financial stability efforts.
- •U.S. Federal Cannabis Policy Progress (Q3-Q4 2026): Any legislative movement on SAFE Banking Act or DEA rescheduling of cannabis would signal clearer path to U.S. market entry for Acreage Holdings.
Medium-Term (6-18 months)
- •Acreage Holdings Integration Roadmap (H1 2027): Specific details on post-legalization integration strategy and market entry plans for Acreage Holdings (e.g., target states, distribution channels) would provide clarity on U.S. revenue potential.
- •New Canadian Market Share Gains (FY2027): If Canopy Growth maintains >20% YoY cannabis net revenue growth, it demonstrates continued brand strength and execution in its core market, signaling potential for similar success in the U.S.
Long-Term (18+ months)
- •Full U.S. Federal Legalization (2028-2029): Complete federal legalization, allowing full U.S. market access and the ability to fully acquire and integrate Acreage Holdings, could unlock billions in annual revenue, justifying a multi-billion dollar valuation.
- •Sustained Profitability (FY2028-2029): Achievement of consistent positive free cash flow and net income, driven by economies of scale in the U.S. and improved gross margins, would significantly re-rate the stock to higher multiples.
Catalysts & Growth Drivers
Sign up free to see growth catalysts
What's the Bull Case for CGC?
- ✓
Quarterly cannabis net revenue growth consistently above 15% YoY.
- ✓
Adjusted EBITDA trending towards and achieving sustained positivity ($0M or above).
- ✓
Specific U.S. federal legislative milestones (e.g., passage of SAFE Banking in Congress or DEA reclassification of cannabis).
Bull Case Analysis
Sign up free to see the bull case
📊 Explore More Stock Analysis
Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential with our AI-powered analysis.
How Canopy Growth Corp Makes Money
Canopy Growth is a Canadian-based cannabis company focused on producing, distributing, and selling a diversified portfolio of cannabis products for medical and recreational (adult-use) purposes. It operates licensed cultivation and processing facilities, along with a retail presence in Canada, and strategically holds a contingent interest in U.S.-based Acreage Holdings to rapidly enter the larger U.S. market once federal prohibition is lifted, diversifying its revenue streams across different product categories like flower, oils, edibles, and beverages.
Read Full Business Model BreakdownFAQ
What is the DVR Score for Canopy Growth Corp (CGC)?
As of June 15, 2026, Canopy Growth Corp has a DVR Score of 7.1 out of 10, placing it in the "Solid Pick" category. This score is generated by our AI-powered deep value analysis framework that evaluates growth potential, financial health, competitive moat, and risk factors.
What is the market capitalization of Canopy Growth Corp?
Canopy Growth Corp's market capitalization is approximately $642.8M..
What is the risk level for CGC stock?
Our analysis rates Canopy Growth Corp's overall risk as Aggressive. This assessment considers execution risk, market risk, financial risk, competitive risk, and regulatory risk. For a full breakdown, see the risk analysis section above.
What is the P/E ratio of CGC?
Canopy Growth Corp currently has a price-to-earnings (P/E) ratio of -0.8. This is below the market average, which could indicate the stock is undervalued or facing headwinds.
Is Canopy Growth Corp's revenue growing?
Canopy Growth Corp has reported revenue growth of 0.6%. The company is growing at a moderate pace.
Is CGC stock profitable?
Canopy Growth Corp has a profit margin of -117.3%. The company is currently unprofitable.
How often is the CGC DVR analysis updated?
Our AI-powered analysis of Canopy Growth Corp is refreshed regularly to incorporate the latest financial data, market conditions, and news. The most recent update was on June 15, 2026.
Important Disclaimer – Not Financial Advice
Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided on this page for CGC (Canopy Growth Corp) should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.
All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research, consider your financial situation, and consult with a qualified financial advisor before making any investment decisions.